Association of-55CT polymorphism of UCP3 gene with fat distribution, cardiovascular risk factors and adipocytokines in patients with Type 2 diabetes mellitus

被引:2
|
作者
de Luis, D. A.
Aller, R.
Izaola, O.
Gonzalez Sagrado, M.
Conde, R.
机构
[1] Univ Valladolid, Hosp Rio Hortega, Inst Endocrinol & Nutr, Sch Med, Valladolid 47130, Spain
[2] Univ Valladolid, Hosp Rio Hortega, Unit Invest, Valladolid 47130, Spain
关键词
55CT polymorphism of UCP3 gene; cardiovascular risk factors; Type 2 diabetes mellitus; fat mass; HUMAN UNCOUPLING PROTEIN-3; BROWN ADIPOSE-TISSUE; BODY-MASS INDEX; SKELETAL-MUSCLE; OBESITY; POPULATION; PREVALENCE; EXPRESSION; PROMOTER; LINKAGE;
D O I
10.3275/7908
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Some studies have pointed to a role of uncoupling protein 3 (UCP3) in the regulation of fat distribution. The aim of our study was to investigate the influence of -55CT polymorphism of UCP3 gene on fat mass and adipocytokines in naive patients with Type 2 diabetes mellitus. Design: A population of 57 patients with Type 2 diabetes mellitus and obesity was analyzed in a cross-sectional study. Genotype of UCP3 gene -55CT was studied. Results: Forty-six patients (80.7%) had the 55CC genotype and 11 patients (19.3%) the 55CT genotype. Fat mass (39.1 +/- 15.4 vs 53.3 +/- 16.8 kg; p<0.05), weight (92.6 +/- 17.7 vs 106.3 +/- 17.3 kg; p<0.05), body mass index (36.2 +/- 6.5 vs 42.8 +/- 5.2 kg/m(2); p<0.05), waist circumference (112.8 +/- 13.6 vs 127.9 +/- 12.3 cm; p<0.05), waist-to-hip ratio (0.96 +/- 0.1 vs 1.1 +/- 0.2; p<0.05), C reactive protein (6.1 +/- 5.1 vs 12.4 +/- 6.1 mg/di; p<0.05) and leptin (92.8 +/- 86 vs 114 +/- 89 ng/ml; p<0.05) were higher in patients with mutant genotype than in those with wild genotype. Conclusion: C reactive protein and fat mass were higher in the mutant group of -55 CT UCP3 gene diabetic patients than in wild type patients. (J. Endocrinol. Invest. 35: 625-628, 2012) (C)2012, Editrice Kurt's
引用
收藏
页码:625 / 628
页数:4
相关论文
共 50 条
  • [21] Cardiovascular risk factors in patients with type 2 diabetes mellitus
    Carolina Vintimilla, Evelin
    Vintimilla Molina, Jhojana Rosati
    Carmendel Rocio Parra
    Martinez Santander, Diana Antonieta
    Martinez Santander, Carlos Jose
    del Rocio Andrade, Neida
    Cumbe Guerrero, Karla Maria
    Cardenas Heredia, Fredy Rosendo
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2018, 13 (04): : 356 - 360
  • [22] Independent Contribution of the-55CT Polymorphism of UCP3 and Daily Energy Intake to Body Weight Regulation in Type 2 Diabetic Patients
    Lapice, Emanuela
    Vaccaro, Olga
    Cocozza, Sara
    Monticelli, Antonella
    Pinelli, Michele
    Riccardi, Gabriele
    DIABETES, 2013, 62 : A702 - A702
  • [23] Association of UCP3, APN, and TNF-α Gene Polymorphisms with Type 2 Diabetes in a Population of Northern Chinese Han Patients
    Wang Ling-ling
    Du Zhen-wu
    Liu Jia-nan
    Wu Mei
    Song Yang
    Jiang Ri-hua
    Zhang Gui-zhen
    CHEMICAL RESEARCH IN CHINESE UNIVERSITIES, 2012, 28 (02) : 255 - 258
  • [24] Association of UCP3,APN,and TNF-α Gene Polymorphisms with Type 2 Diabetes in a Population of Northern Chinese Han Patients
    WANG Ling-ling 1
    3.Department of Neurology
    Chemical Research in Chinese Universities, 2012, 28 (02) : 255 - 258
  • [25] Risk Factors and cardiovascular Outcomes in Patients with type 2 Diabetes Mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2018, 14 (07): : 499 - 500
  • [26] Assessment of Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus
    Ramona, Dragut R.
    Rusu, Emilia
    Radulian, Gabriela
    Parpala, Cristina
    Popescu, Horatiu
    Nan, Raluca
    DIABETES, 2012, 61 : A562 - A563
  • [27] Modulation of Insulin Concentrations and Metabolic Parameters in Obese Patients by-55CT Polymorphism of the UCP3 Gene Secondary to Two Hypocaloric Diets
    de Luis, D. A.
    Aller, R.
    Izaola, O.
    Sagrado, M. Gonzalez
    Conde, R.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (01) : 62 - 66
  • [28] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152
  • [29] Body fat, fat distribution, and psychosocial factors among patients with Type 2 diabetes mellitus
    Bell, RA
    Summerson, JH
    Spangler, JG
    Konen, JC
    BEHAVIORAL MEDICINE, 1998, 24 (03) : 138 - 143
  • [30] Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
    Budoff, Matthew J.
    Wilding, John P. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (05)